Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromes.

Blood Cancer J · 2025 · PMC11976984 · PMID 40195329

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.080so close (0.05 < p ≤ 0.1)

Although multi-hit ones showed a similar trend, the difference did not reach statistical significance (57.7% vs. 45.0%, P = 0.080).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.